Friday, 17 Aug 2018

TNF inhibitor

Datesort ascending Type Title Save
06 Sep 2015 Social 2013 global sales: ETN $11.1 bill, INFL 9.9 bill, ADA 8.9 bill. RA sales increase from $56B in 2013 to $80B in 2020 http://t.co/2zWeVhP3XF
04 Aug 2015 Social Animal model chronic inflammation: probiotics decrease TNF, improve socialization, but no effx on liver inflammation http://t.co/gapL5A5TTM
25 Jul 2015 Social Metanalysis 40 RCTs & >10K TNF its show TB risk 0.26% (OR=25), higher in TNF+MTX (OR = 58) vs TNF mono therapy (OR=4) http://t.co/tqk1ArA7uc
22 Jul 2015 Social Comparative biologic risk of TB Among 75000 pts: 31 TB due to TNFi, 1 w/ ABA; none w/ RTX, TCZ, Tofa, ustekinumab http://t.co/cG8ranlUCN
14 Jul 2015 Social ESPGHAN cautions on biosimilar use; studies on safety & immunogenicity should be mandatory in children w/ IBD http://t.co/Gpa6HmP2U5
09 Jul 2015 Social 1964 Turkish pts Rx w/ TNF inhibitors- TB rate of 466/100,000. TB risk greatest w/ Behcets; lower if PPD >10mm http://t.co/rWJIBKA3MO
08 Jul 2015 News Neurologic Events with TNF Inhibitor Therapy
08 Jul 2015 Social TNF inhib use causes steatohepatitis? VA report 8 pts shows TNFi, MTX & PNPLA3 gene mutations may be risks for NAFLD http://t.co/HuxmtZsU62
05 Jul 2015 News Adalimumab Drug Levels Predict Efficacy
05 Jul 2015 Social Hospira's Infectra biosimilar sold at 45% discount by a major French hospital group covering 1/4 of French population http://t.co/KSQoi6hG29
01 Jul 2015 Social EMA recommends Humira for Rx of hydradenitis suppurativa based on >6000 pts. FDA granted orphan status in May 2015 http://t.co/WNn9ed3bXB
30 Jun 2015 News Utility of Drug Levels and Anti-Drug Antibodies When Starting TNF inhibitors
29 Jun 2015 Social EU approves Simponi for Rx of adults with severe, non-radiographic axial spondyloarthritis, based on GO-AHEAD study. http://t.co/FqnMq2MpIY
23 Jun 2015 News Adherence to ETN/MTX is Greater Than Triple DMARD Therapy
18 Jun 2015 News Frequency of Infliximab Infusion Reactions
15 Jun 2015 Social #EULAR2015 OPTTIRA study: 97 LDAS RA pts (#SAT0150) tapered TNFi by 1/3 ->14% flares, 2/3-> 34% flares. 45% D/C TNFi http://t.co/hE5aHROD6P
05 Jun 2015 News Conventional DMARDs extend TNF inhibitor drug survival in patients with spondyloarthropathies
28 May 2015 Social Pt directed TNFi dose reduction in 58 Ank Spondylitis pts 94% effective @6 mos but only maintained in 54% over 2 yrs http://t.co/ALU5YezW6t
27 May 2015 News Nonadherence to Self-Injected Biologics is High
22 May 2015 News Amgen & Abbvie Increase the Price of TNF Inhibitors